2020 annual financial data
Lyell Immunopharma 2020 Operating margin
Lyell Immunopharma 2020 operating margin with verified reported values.
Direct answer
Operating margin was -2,732.56%.
Operating income was -211,937,000 USD and net income was -204,472,000 USD.
Operating cash flow was -160,874,000 USD.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,756,000 USD
- Operating income
- -211,937,000 USD
- Net income
- -204,472,000 USD
- Operating cash flow
- -160,874,000 USD